Bakirci, S. Et Al. 2019. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.5 , 808-812.

Bakirci, S., Solmaz, D., Al Osaimi, N., Dalkilic, E., Can, M., Erden, A., ... Ozisler, C.(2019). What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.5, 808-812.

Bakirci, S. Et Al. "What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.5, 808-812, 2019

Bakirci, S. Et Al. "What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.5, pp.808-812, 2019

Bakirci, S. Et Al. (2019) . "What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.37, no.5, pp.808-812.

@article{article, author={S. Bakirci Et Al. }, title={What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2019, pages={808-812} }